The term chronic obstructive pulmonary disease (COPD) covers a complex group of disorders characterized by a progressive development of airflow limitation. Key risk factors of the disease are cigarette smoke and air pollution. In addition, a genetic component is involved in the development of COPD. It is set to become the third leading cause of death in the developed world by 2020.
AZD‐9668 is a protease (lactase) inhibitor.
I. Presentation - General Information
II. Chronic Obstructive Pulmonary
New Treatments for COPD
IV. Clinical Trials
|Publication date:||Number of pages:||Price:|